title: Thromboembolic disease in pregnancy.
abstract: Venous thromboembolic disease is a major cause of maternal morbidity and mortality. Virchow's triad of hypercoagulability, venous stasis, and vascular damage all occur during pregnancy. The risk of venous thromboembolism is five to six times higher during pregnancy and the puerperium. Risk factors include age greater than 35, antiphospholipid antibodies, inherited thrombophilias, operative delivery, increased parity, obesity, mechanical heart valves,and family history. Prophylactic and therapeutic anticoagulation is recommended for women at risk. Low molecular weight heparins are safe and effective in most cases.
authors.affiliation: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA. nora.m.doyle@uth.tmc.edu
authors.forename: Nora M
authors.initials: NM
authors.lastname: Doyle
authors.forename: Manju
authors.initials: M
authors.lastname: Monga
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis* / Q000628:therapy*; D011295:Prenatal Care; D019851:Thrombophilia / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*
chemical_list: D000925:Anticoagulants